George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR / PCA Dealing

1 Nov 2017 17:18

RNS Number : 3199V
Ideagen PLC
01 November 2017
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

PDMR / PCA Dealing

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that on 31 October 2017, Tri Castle Investments Ltd, a company wholly controlled by Jonathan Wearing, Non-Executive Chairman of the Company, sold 100,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at 79 pence per Ordinary Share (the "Transaction").

Following the Transaction, Jonathan Wearing will have a beneficial interest in 4,339,066 Ordinary Shares, representing approximately 2.17 % of the current issued share capital of the Company.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jonathan Wearing

2.

Reason for the Notification

a)

Position/status

Persons Closely Associated with Jonathan Wearing, Non-Executive Chairman of the Company

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

LEI

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Disposal of ordinary shares of 1 pence each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Disposal of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

79 pence

100,000

d)

Aggregated information:

· Aggregated volume

· Price

 

100,000 ordinary shares of 1 pence each at 79 pence per ordinary share

e)

Date of the transaction

31 October 2017

f)

Place of the transaction

London Stock Exchange, AIM Market

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

 About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAXFFEFSXFFF
Date   Source Headline
8th Jul 20227:00 amRNSCancellation - Ideagen Plc
8th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
7th Jul 20223:45 pmRNSHolding(s) in Company
7th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
7th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
7th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
7th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
7th Jul 20221:19 pmGNWForm 8.3 - Ideagen PLC
7th Jul 202211:21 amRNSForm 8.3 - Ideagen plc
7th Jul 202210:39 amRNSForm 8.5 (EPT/RI)
7th Jul 20229:08 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
7th Jul 20227:30 amRNSSuspension – Ideagen PLC
7th Jul 20227:00 amRNSHolding(s) in Company
7th Jul 20227:00 amRNSScheme becomes Effective
6th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
6th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
6th Jul 20223:10 pmRNSHolding(s) in Company
6th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
6th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
6th Jul 202211:41 amRNSForm 8.5 (EPT/RI)
6th Jul 202211:08 amGNWForm 8.3 - [IDEAGEN PLC - 05 07 2022] - (CGWL)
6th Jul 202211:03 amRNSForm 8.3 - IDEAGEN PLC
6th Jul 20229:09 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
5th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
5th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
5th Jul 20222:30 pmRNSExercise of Options, Issue of Equity and Rule 2.9
5th Jul 20222:20 pmRNSCourt Sanction of Scheme of Arrangement
5th Jul 202212:24 pmGNWForm 8.3 - [IDEAGEN PLC 04 07 2022] - (CGWL)
5th Jul 202212:13 pmRNSDisclosure under Rule 26
5th Jul 202212:10 pmRNSForm 8.3 - Ideagen plc
5th Jul 202210:58 amRNSForm 8.5 (EPT/RI)
5th Jul 20228:13 amRNSForm 8.5 (EPT/RI)
4th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
4th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
4th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
4th Jul 20222:30 pmRNSHolding(s) in Company
4th Jul 202212:07 pmRNSForm 8.3 - Ideagen plc
4th Jul 202210:55 amRNSForm 8.5 (EPT/RI)
4th Jul 202210:47 amGNWForm 8.3 - [IDEAGEN PLC - 01 07 2022] - (CGWL)
4th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
1st Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
1st Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:11 pmGNWForm 8.3 - [Ideagen plc - 30 06 2022] - (CGWL)
1st Jul 20223:09 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
1st Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
1st Jul 202212:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.